日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunization

因Rh抗原同种免疫引起的胎儿和新生儿溶血病的严重程度特征

Krumme, Alexis A; Suruki, Robert Y; Blacketer, Clair; Hardin, Jill; Swerdel, Joel N; Tjoa, May Lee; Markham, Kara B

The necessity of validity diagnostics when drawing causal inferences from observational data: lessons from a multi-database evaluation of the risk of non-infectious uveitis among patients exposed to Remicade(®)

从观察数据中得出因果推断时进行有效性诊断的必要性:来自对接触 Remicade® 的患者发生非感染性葡萄膜炎风险的多数据库评估的教训

Weaver, James; Voss, Erica A; Cafri, Guy; Beyrau, Kathleen; Nashleanas, Michelle; Suruki, Robert

Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases

美国医疗保险数据库分析显示,强直性脊柱炎、银屑病关节炎和类风湿性关节炎患者在诊断和随访期间的阿片类药物使用情况

Sheahan, Anna; Anjohrin, Suzanne; Suruki, Robert; Stark, Jeffrey L; Sloan, Victor S

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study

评论:银屑病关节炎患者接受生物制剂/阿普米司特治疗后发生重大不良心血管事件的风险:一项全国性队列研究

Suruki, Robert Y; Desai, Rishi J; Davis, Kourtney J; Berlin, Jesse A; Gagne, Joshua J

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study

德国类风湿性关节炎、银屑病关节炎和银屑病患者的流行病学和治疗:一项真实世界证据研究

Grellmann, Claudia; Dombrowsky, Wojciech; Fabricius, Volker; Suruki, Robert; Sheahan, Anna; Joeres, Lars

Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis

银屑病合并关节疾病的临床负担:一项基于美国医疗保险索赔和电子健康记录数据库的分析

Skornicki, Michelle; Prince, Patricia; Suruki, Robert; Lee, Edward; Louder, Anthony

Psychosocial stress, sleep quality and interest in mind-body integrative health sleep intervention among urban adolescents in the school-based health setting

城市青少年在校内健康环境中的心理社会压力、睡眠质量以及对身心整合健康睡眠干预的兴趣

Garbers, Samantha; Suruki, Caitlyn; Falletta, Katherine A; Gold, Melanie A; Bruzzese, Jean-Marie

Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy

与免疫检查点抑制剂 (ICI) 治疗相关的可能风湿性免疫相关不良事件 (rh-irAEs) 的发生

Anjohrin, Suzanne; Sheahan, Anna; Suruki, Robert; Stark, Jeffrey L; Sloan, Victor S

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases

利用Medicare和MarketScan数据库分析美国强直性脊柱炎和中轴型脊柱关节炎的年度诊断患病率

Curtis, Jeffrey R; Winthrop, Kevin; Bohn, Rhonda L; Suruki, Robert; Siegel, Sarah; Stark, Jeffrey L; Xie, Fenglong; Yun, Huifeng; Chen, Lang; Deodhar, Atul

One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry

在真实世界环境中,接受塞妥珠单抗聚乙二醇治疗的患者与接受其他TNF抑制剂治疗的患者相比,一年内发生严重感染的风险:来自美国国家类风湿性关节炎登记处的数据

Harrold, Leslie R; Litman, Heather J; Saunders, Katherine C; Dandreo, Kimberly J; Gershenson, Bernice; Greenberg, Jeffrey D; Low, Robert; Stark, Jeffrey; Suruki, Robert; Jaganathan, Srihari; Kremer, Joel M; Yassine, Mohamed